Maintenance Engineer - ref. q24346003
Job description:
We use science to save lives, and so can you.
We are currently recruiting for an experienced Engineer to evaluate assets, determine and execute routine preventative maintenance activities and procedures and assess and implement major fault repairs.
OXB’s Engineering team are responsible for all aspects of Plant, Mechanical, Electrical, and incoming utilities at our facilities.
Your responsibilities in this role would be:
- Taking accountability for completion of assigned routine preventative maintenance activities.
- Responding to breakdowns of equipment, assessment, diagnosis, repair of faults or escalation.
- Co-ordinating of OXB’s external engineering resource in relationship to specialist repairs and maintenance of assets.
- Completing regulatory routine monitoring (Legionella tap temperatures for example)
- Evaluating asset performance against determined criteria.
- Completing quality documentation for critical failures.
- Identifying spares stock availability.
- Escalating events impacting engineering assets.
We are looking for:
- A minimum of 5 GCSE’s (or equivalent) including Maths and English
- An apprenticeship within a relevant discipline, NVQ 3 Level 3, City & Guilds or equivalent is preferred.
- Proven experience within an engineering maintenance function.
- Experience within a GxP Pharmaceutical/Biotech industry is preferred.
- Good computer Literacy skills with experience of Microsoft Office suite software.
- Experience in regulatory/statutory regulations.
- Good working knowledge of Health and Safety within an Engineering environment
About Us:
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation.These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
What’s in it for you:
- Highly competitive total reward packages
- Wellbeing programmes
- Development opportunities
- Welcoming, friendly, supportive colleagues
- A diverse and inclusive working environment
- Our values are: Responsible, Responsive, Resilient, Respect
- State of the art laboratory and manufacturing facilities
We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.
Collaborate. Contribute. Change lives
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells.This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors.Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.